Minneapolis Va Health Care System, Minneapolis MN
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shiroma, Paulo R
VAST-D II, NCT05554627: VA Aripiprazole vs Esketamine for Treatment Resistant Depression

Withdrawn
4
940
US
Esketamine, Spravato (for depression), Ketanest (for anesthesia), Aripiprazole, Abilify, Aristada
VA Office of Research and Development
Depressive Disorder, Major
10/23
10/23
NCT06228391: Ketamine Treatment for PTSD and MDD in TBI

Not yet recruiting
2
40
US
IV ketamine, Midazolam
Minneapolis Veterans Affairs Medical Center
PTSD, Post Traumatic Stress Disorder, Major Depressive Disorder, Traumatic Brain Injury
12/26
03/27
NCT04560660: Ketamine-enhanced Prolonged Exposure Therapy in PTSD

Recruiting
2
100
US
Ketamine, Midazolam
VA Office of Research and Development
PTSD
12/24
10/25
Albott, Cristina S
NCT04032301: Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

Recruiting
1
108
US
Ketamine, Ketamine Hydrochloride, Normal Saline, Sodium Chloride in Water
University of Minnesota, Minneapolis Veterans Affairs Medical Center
Post-Traumatic Stress Disorders, Major Depressive Disorder
04/24
04/25
NCT04396600: The Professional Peer Resilience Initiative

Enrolling by invitation
N/A
1200
US
MinnRAP Peer Support Program
University of Minnesota
Stress, Stress Disorder, Stress, Psychological, Trauma, Psychological, Anxiety, Anxiety State, Post Traumatic Stress Disorder, Secondary Traumatic Stress, Professional Quality of Life, Stress Related Disorder, Stress Reaction, Stress Risk, Mental Resilience, Emotional Resilience
12/24
12/24

Download Options